Interagency Working Group on Healthcare Quality
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
OD/DPCPSI/OBSSR, FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM
|
Includes representation from all major deparments that examine issues regarding the quality of healthcare.
|
Interagency Working Group on Neuroscience
|
Other
|
CDC, FDA
|
NIMH, NIA, NIDA, NINDS, NINR, OD/DPCPSI/OBSSR
|
By Executive Order, the White House Office of Science and Technology Policy (OSTP) established the Interagency Working Group on Neuroscience by action of the National Science and Technology Council (NSTC) to foster collaboration across agencies and to coordinate Federal investments in neuroscience research. The Interagency Working Group on Neuroscience will coordinate activities in neuroscience research across the Federal government with a focus on the fundamental understanding of learning, brain development and plasticity, and brain health and recovery. The working group will enhance Federal efforts related to: improving our understanding of learning and cognition and applying that to improvements in education and other areas; improving our understanding of a variety of neurological conditions and injuries; and developing appropriate resources, tools, techniques, interventions, and therapies to assist in research, treatment, and recovery. The NSTC working group includes members from the Departments of Agriculture, Defense, Education, Energy, Health and Human Services, Homeland Security, Justice, and Veterans Affairs, as well as the Central Intelligence Agency, Environmental Protection Agency, National Aeronautics and Space Administration, the National Science Foundation, and the Office of the Director of National Intelligence.
|
Interagency Working Group on Youth Programs
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC
|
NIAAA, NIDA
|
The Interagency Working Group on Youth Programs (IWGYP), which is composed of representatives from 12 Federal Departments and 5 Federal Agencies that support programs and services focusing on youth. The IWGYP promotes the goal of positive, healthy outcomes for youth.
|
INTERMACS - Interagency Registry for Mechanically Assisted Circulatory Support
|
Resource Development
|
CMS, FDA
|
NHLBI
|
The Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) is a national registry for patients who are receiving mechanical circulatory support device therapy to treat advanced heart failure. This registry was devised as a joint effort of the National Heart, Lung, and Blood Institute (NHLBI), the Centers for Medicare and Medicaid Services (CMS), the U.S. Food and Drug Administration (FDA), clinicians, scientists, and industry representatives, in conjunction with the University of Alabama at Birmingham and the United Network for Organ Sharing.
|
International Cancer Control Partnership
|
Other
|
CDC
|
NCI
|
The National Cancer Institute and the Union for International Cancer Control convened global partners including CDC to cooperate in assisting countries to develop and implement quality cancer plans linked to Non-communicable Disease (NCD) control. This International Cancer Control Partnership, ICCP, believes that prioritizing cancer is critical to reaching the “25x25” goal. ICCP partners will assist countries by: creating a searchable database of current cancer control plans from around the globe; performing analysis of gaps and highlighting priority areas for inclusion in plans; training appropriate personnel to develop plans with targets and evaluation strategies; providing planners with relevant existing materials and tools; and offering technical assistance. ICCP partners will use their collective state, country and regional-level planning experience to guide plan development and implementation and will ensure planners utilize effective, evidence-based strategies to help meet the global NCD targets.
|
Intradepartmental Council for Native American Affairs (ICNAA)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIMHD
|
The purpose of this collaborative activity is to support activities of the Intradepartmental Council for Native American Affairs (ICNAA), including tribal consultation sessions and development of the annual tribal consultation report.
|
Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP, NCI, NIAID
|
The Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC) makes technically based recommendations to the APHIS/CDC Select Agent and Toxin Program on restricted experiments of Select Agents and Toxins and the exclusion and exemption of attenuated strains. The Committee also conducts a biennial review of the Select Agents and Toxins list for HHS and overlap agents and toxins.
|
Investigations into Health Effects Caused by Exposure to Indoor Air Reaction Products
|
Research Initiative
|
CDC
|
NIEHS
|
Ongoing studies are identifying and quantifying the volatile reaction products of gas-phase compounds present in the indoor environment, especially dicarbonyls, and investigating immunotoxic and hypersensitivity effects of these reaction products in both in vitro and in vivo models.
|
Investigations of Early Life Determinants of Pediatric and Adult Malignancies in a Population
|
Research Initiative
|
CDC
|
NCI
|
In collaboration with investigators from the U.S. Centers for Disease Control and Prevention (CDC) and the China CDC, the National Cancer Institute (NCI) is assessing risk of pediatric leukemia and other pediatric cancers in a large population of offspring of mothers enrolled in a community intervention program of peri-conception folic acid supplementation in China. Pediatric cancer risks will be compared in offspring of mothers treated vs offspring of mothers not treated with folic acid supplements.
|
Iron and Malaria Research Project
|
Research Initiative
|
CDC, OS
|
NICHD, NIAID
|
In November 2007, the NICHD launched the Iron and Malaria Project to identify and examine factors that affect the safety and effectiveness of interventions to prevent iron deficiency in the context of malaria and other infections. The Project is funded, in part, by the Bill and Melinda Gates Foundation with additional support from the NIH Office of Dietary Supplements. The Project aims not only to generate new data to address this high-priority global health issue, but also to support efforts of the World Health Organization (WHO) to develop evidence-based guidelines with specific regard to the use of iron interventions. The Project and its goals grew out of new research that examined historical concerns about the safety of iron supplementation and, in particular, evidence of an increased risk for poor health outcomes among those (primarily young children) who were not iron deficient, but who received iron supplementation as part of “universal” supplementation programs in regions where malaria and other infections are common. The objective of this meeting was to assess progress of the funded grants and discuss the research project. This project has 3 sub-projects with direct collaborations with CDC: 1) Inflammation and nutrition science for programs/policy and interpretation of research evidence (INSPIRE); 2) Soluble transferrin receptor (sTfr) standard material development project to help provide standards to evaluate reliability and validity of assays to measure sTfr, a biomarker of iron status; and 3) Biomarkers reflecting inflammation and nutritional determinants of anemia (BRINDA).
|